Cargando…

Radiotherapy for esophageal carcinoma: dose, response and survival

Esophageal cancer (EC) is an extremely aggressive, lethal malignancy that is increasing in incidence worldwide. At present, definitive chemoradiotherapy is accepted as the standard treatment for locally advanced EC. The EC guidelines recommend a radiation dose of 50.4 Gy for definitive treatment, ye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Yijun, Mao, Qingfeng, Wang, Xiaoli, Yu, Jinming, Li, Minghuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749557/ https://www.ncbi.nlm.nih.gov/pubmed/29343986 http://dx.doi.org/10.2147/CMAR.S144687

Ejemplares similares

Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice
por: Li, Minghuan, et al.
Publicado: (2016)

A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy
por: Wang, Xin, et al.
Publicado: (2020)

The flow-metabolism ratio might predict treatment response and survival in patients with locally advanced esophageal squamous cell carcinoma
por: Zhao, Kewei, et al.
Publicado: (2020)

Identification of risk factors and the pattern of lower cervical lymph node metastasis in esophageal cancer: implications for radiotherapy target delineation
por: Luo, Yijun, et al.
Publicado: (2017)

Dose-escalated radiotherapy improved survival for esophageal cancer patients with a clinical complete response after standard-dose radiotherapy with concurrent chemotherapy
por: Zhang, Wei, et al.
Publicado: (2018)

Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation
por: Zhu, Yingming, et al.
Publicado: (2016)

The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy
por: Liu, Xuemei, et al.
Publicado: (2017)

A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy
por: Wang, Peiliang, et al.
Publicado: (2021)

Details of out-field regional recurrence after involved-field irradiation with concurrent chemotherapy for locally advanced esophageal squamous cell carcinoma
por: Zhang, Xiaoli, et al.
Publicado: (2016)

Recurrence pattern of squamous cell carcinoma in the midthoracic esophagus: implications for the clinical target volume design of postoperative radiotherapy
por: Wang, Xiaoli, et al.
Publicado: (2016)

Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma
por: Zhao, Kewei, et al.
Publicado: (2020)

Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy
por: Zhao, Zongxing, et al.
Publicado: (2020)

Consolidative thoracic radiotherapy for extensive stage small cell lung cancer
por: Zhang, Xiaoli, et al.
Publicado: (2017)

Lymph node metastasis is not associated with survival in patients with clinical stage T4 esophageal squamous cell carcinoma undergoing definitive radiotherapy or chemoradiotherapy
por: Zhu, Liqiong, et al.
Publicado: (2022)

The expression of p‐p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance
por: Wang, Zhe, et al.
Publicado: (2019)

Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
por: Zhang, Xiaoli, et al.
Publicado: (2014)

18F-fluorodeoxyglucose positron emission tomography predicts lymph node responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients
por: Zhu, Wenyao, et al.
Publicado: (2018)

Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients
por: Wang, Xin, et al.
Publicado: (2020)

Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy
por: Zhang, Jingze, et al.
Publicado: (2018)

Corrigendum: Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients
por: Wang, Xin, et al.
Publicado: (2021)

Management of salivary gland carcinomas - a review
por: Wang, Xiaoli, et al.
Publicado: (2016)

The impact of the nodal status on the overall survival of non-surgical patients with esophageal squamous cell carcinoma
por: Zhao, Zongxing, et al.
Publicado: (2019)

Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer
por: Xing, Jun, et al.
Publicado: (2016)

Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute
por: Jing, Wang, et al.
Publicado: (2015)

Overexpression of Cdc25C predicts response to radiotherapy and survival in esophageal squamous cell carcinoma patients treated with radiotherapy followed by surgery
por: Li, Bao-Zhong, et al.
Publicado: (2013)

Primary tumor location is an important predictor of survival in pulmonary adenocarcinoma
por: Wang, Zhe, et al.
Publicado: (2019)

The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review
por: Zhang, Xiaoli, et al.
Publicado: (2016)

Correction: Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute
por: Jing, Wang, et al.
Publicado: (2016)

Heart Dosimetric Parameters Were Associated With Cardiac Events and Overall Survival for Patients With Locally Advanced Esophageal Cancer Receiving Definitive Radiotherapy
por: Cai, Guoxin, et al.
Publicado: (2020)

High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy
por: Wang, Chunyu, et al.
Publicado: (2015)

Development and validation of a risk prediction model for radiotherapy-related esophageal fistula in esophageal cancer
por: Xu, Yiyue, et al.
Publicado: (2019)

Postoperative Radiotherapy for Thoracic Esophageal Carcinoma with Upfront R0 Esophagectomy
por: Wang, Yichun, et al.
Publicado: (2020)

Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy
por: Pao, Tzu-Hui, et al.
Publicado: (2020)

Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma
por: An, Lingbo, et al.
Publicado: (2023)

The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
por: Lo, Chien-Ming, et al.
Publicado: (2021)

High expression level of peptidylprolyl isomerase A is correlated with poor prognosis of liver hepatocellular carcinoma
por: Wang, Shilong, et al.
Publicado: (2019)

Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma
por: Han, Weiming, et al.
Publicado: (2022)

Esophageal perforation during or after conformal radiotherapy for esophageal carcinoma
por: Chen, Hai-yan, et al.
Publicado: (2014)

Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients
por: Liu, Ao, et al.
Publicado: (2021)

Baseline FDG Uptake And Peripheral Lymphocyte-Monocyte Ratio For Predicting Chemoradiotherapy Response In Patients With Esophageal Squamous Cell Carcinoma
por: Wang, Chunsheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2f1vjbp174o31gp0dgn12hvsr8